Results 51 to 60 of about 2,752 (167)
The Risk of Venous Thromboembolism Associated with Oral Contraceptive; the Search Is Still On
Archives of Academic Emergency Medicine, 2018 A few years after coming to the market, the first generation of oral contraceptive pills (OCPs) were linked to significant risk of venous thromboembolism (VTE). This increased risk was blamed on the presence of the estrogen-like compounds in these agents.
Ali Abdalvand
doaj +1 more source
Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 5, Page 805-818, May 2026.Hormonal treatments for endometriosis (combined oral contraceptives/progestin‐only pills) do not show increased psychological or sexual risks compared with placebo. When pain is effectively controlled, these therapies appear well tolerated and may improve overall well‐being.
Noemi Salmeri +5 more
wiley +1 more source
Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 4, Page 568-574, April 2026.It is expected that the relugolix estetrol combination RE4W will enable women to control their fertility and prevent menstrual cycle related problems, while offering a smooth transition through perimenopause into the postmenopause and decrease the risk of breast cancer.
Herjan J. T. Coelingh Bennink +9 more
wiley +1 more source
, 2000 Combined oral contraceptives (OC) are known to increase the risk of venous thromboembolism. The aim of this randomized, cycle-controlled, cross-over study in 28 healthy volunteers was to assess potential differences between the effects of an OC ...
van Enk, A. +17 more
core +1 more source
NON-DEVELOPING PREGNANCY. THE ROLE OF HORMONAL CONTRACEPTION IN REHABILITATION TREATMENT
Акушерство, гинекология и репродукция, 2016 Non-developing pregnancy (NB) is main factor of reproductive losses. The stress developed after the NB like after the abortion which accompanied with excitation of the hypothalamic-pituitary system.
G. B. Dikke
doaj
Hormonal contraception with desogestrel-induced medication use [PDF]
Гинекология, 2014 This article presents current information on existing methods hormonal contraception, covered medical and clinical aspects acceptability of hormonal contraceptives.An important emphasis is made on the benefits of Laktinet® in women of postpartum period ...
S A Levakov, N A Sheshukova
doaj
Pharmacokinetic evaluation of desogestrel as a female contraceptive
, 2014 Desogestrel (DSG) is a third-generation 19-nortestosterone derivative progestogen. It is contained in many oral contraceptive preparations, both combined (COCs) to ethinyl-estradiol (EE) or alone in a progestin-only pill (POP).
Grand,i Giovanni +3 more
core +1 more source
URGENCY OF COMBINED ORAL CONTRACEPTIVES IN PROLONGED REGIMEN USE
Акушерство, гинекология и репродукция, 2016 This article presents the issues on combined oral contraceptives use in prolonged regimen.
A. L. Tikhomirov, A. A. Ledenkova
doaj
Medical treatment for adenomyosis: long term use of progestins
Gynecological EndocrinologyBackground Adenomyosis is a uterine disorder causing menstruation-related symptoms such as dysmenorrhea, heavy menstrual bleeding (HMB) and dyspareunia. A long-term management of the disease is required.
Silvia Vannuccini +8 more
doaj +1 more source
Contraceptive progestins with androgenic properties stimulate breast epithelial cell proliferation
EMBO Molecular Medicine, 2021 Hormonal contraception exposes women to synthetic progesterone receptor (PR) agonists, progestins, and transiently increases breast cancer risk. How progesterone and progestins affect the breast epithelium is poorly understood because we lack adequate ...
Marie Shamseddin +14 more
doaj +1 more source